Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized phase III study of S-1/Oxaliplatin comparing Tegafur-Uracil/Leucovorin in the Adjuvant chemotherapy of Stage IIIb colorectal cancer

Next Previous
Trial Profile

Randomized phase III study of S-1/Oxaliplatin comparing Tegafur-Uracil/Leucovorin in the Adjuvant chemotherapy of Stage IIIb colorectal cancer

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 07 Dec 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary) ; Folinic acid; Tegafur/uracil
  • Indications Adenocarcinoma; Colorectal cancer; Rectal cancer
  • Focus Registrational; Therapeutic Use
  • Acronyms ACTS-CC 02
  • Sponsors Taiho Pharmaceutical Company

    • Most Recent Events

    • 17 Jan 2021 Status changed from active, no longer recruiting to completed, as per Final Results presented at the 2021 Gastrointestinal Cancers Symposium
    • 17 Jan 2021 Primary endpoint has not been met. (Disease-free survival (DFS), as per Results presented at the 2021 Gastrointestinal Cancers Symposium
    • 17 Jan 2021 Final Results presented at the 2021 Gastrointestinal Cancers Symposium
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top